234 related articles for article (PubMed ID: 18174734)
21. [Hypopituitarism].
Kuribayashi T; Arisaka O
Ryoikibetsu Shokogun Shirizu; 2001; (36):281-5. PubMed ID: 11596391
[No Abstract] [Full Text] [Related]
22. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
[TBL] [Abstract][Full Text] [Related]
23. Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin.
Savas A; Arasil E; Batay F; Selcuki M; Kanpolat Y
Acta Neurochir (Wien); 1999; 141(5):547-8; discussion 549. PubMed ID: 10392216
[No Abstract] [Full Text] [Related]
24. GH deficiency in the elderly: the case for GH replacement.
Shalet SM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):279-80. PubMed ID: 10971443
[No Abstract] [Full Text] [Related]
25. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
[TBL] [Abstract][Full Text] [Related]
26. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
27. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
Hayward R
Childs Nerv Syst; 2002 Nov; 18(11):565; author reply 566. PubMed ID: 12420115
[No Abstract] [Full Text] [Related]
28. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database.
Price DA; Jönsson P
Acta Paediatr Suppl; 1996 Oct; 417():83-5. PubMed ID: 9055921
[TBL] [Abstract][Full Text] [Related]
30. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
Arita K; Hirano H; Tominaga A; Kurisu K
Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
[TBL] [Abstract][Full Text] [Related]
32. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
33. Acute and late morbidity after limited resection and focal radiation therapy in craniopharyngiomas.
Scarzello G; Buzzaccarini MS; Perilongo G; Viscardi E; Faggin R; Carollo C; Calderone M; Franchi A; Sotti G
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():399-405. PubMed ID: 16700317
[TBL] [Abstract][Full Text] [Related]
34. Endocrine aspects and sequel in patients with craniopharyngioma.
Erfurth EM
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):19-26. PubMed ID: 25514328
[TBL] [Abstract][Full Text] [Related]
35. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
36. Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma.
Yuen KC; Kołtowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
J Clin Endocrinol Metab; 2014 Apr; 99(4):1227-35. PubMed ID: 24476077
[TBL] [Abstract][Full Text] [Related]
37. [CranioNet -- an interdisciplinary strategy for craniopharyngioma].
Reschke K; Busse S; Mohnike K; Buchfelder M; Ranke M; Fahlbusch R; Lehnert H
Dtsch Med Wochenschr; 2006 Apr; 131(15):821-4. PubMed ID: 16607603
[TBL] [Abstract][Full Text] [Related]
38. [Endocrine disorders in craniopharyngiomas in children: dependence on the site of a tumor].
Mazerkina NA; Konovalov AN; Gorelyshev SK; Semenova ZhB; Krasnova TS; Tenedieva VD
Zh Vopr Neirokhir Im N N Burdenko; 2008; (1):23-9; discussion 29. PubMed ID: 18488892
[No Abstract] [Full Text] [Related]
39. [Hypopituitarism].
Faust M
Dtsch Med Wochenschr; 2006 Jul; 131(30 Suppl 3):S78-81. PubMed ID: 16933197
[No Abstract] [Full Text] [Related]
40. Micturition Disorders as the First Symptom of Multiple Pituitary Hormone Deficiency Caused by Craniopharyngioma.
Berk K; Powirtowska M; Korzeniecka-Kozerska A
J Paediatr Child Health; 2018 Jan; 54(1):105-106. PubMed ID: 29314378
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
